Nanoparticles as drug delivery agents specific for CNS: in vivo biodistribution

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 5, Issue 4, 2009, Pages 369-377

  Vergoni, Anna Valeria ^a   Tosi, Giovanni ^a   Tacchi, Raffaella ^a   Vandelli, Maria Angela ^a   Bertolini, Alfio ^a   Costantino, Luca ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Biodistribution; Brain diseases; CNS; In vivo experiments; Nanoparticles; Nanotechnology

Indexed keywords

BIODISTRIBUTIONS; BLOOD-BRAIN BARRIER; BRAIN DISEASE; CENTRAL NERVOUS SYSTEMS; CNS; D-GLUCOSE; DRUG CARRIER; HIGH SPECIFICITY; IN-VIVO; IN-VIVO EXPERIMENTS; INTRAVENOUS ADMINISTRATION; LONG LASTING; LOPERAMIDE; MODEL DRUGS; NANO PARTICULATES; NEUROLOGICAL DISORDERS; ORDERS OF MAGNITUDE; PHARMACOLOGICAL EFFECTS; PHARMACOLOGICAL TREATMENT; POLY(D ,L-LACTIDE-CO- GLYCOLIDE); POLYMERIC NANOPARTICLES; TARGETED DRUG DELIVERY;

AMINES; BLOOD; GLUCOSE; NANOPARTICLES; NANOTECHNOLOGY; ORGANIC POLYMERS;

CONTROLLED DRUG DELIVERY;

LOPERAMIDE; NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG EFFICACY; DRUG SPECIFICITY; DRUG TARGETING; IN VIVO STUDY; MALE; NONHUMAN; RAT;

ANIMALS; BIOLOGICAL ASSAY; BRAIN; DRUG DELIVERY SYSTEMS; INJECTIONS, INTRAVENTRICULAR; LOPERAMIDE; MALE; NANOPARTICLES; NOCICEPTORS; PARTICLE SIZE; RATS; RATS, WISTAR; RHODAMINE 123; TISSUE DISTRIBUTION;

EID: 70749114154     PISSN: 15499634     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nano.2009.02.005     Document Type: Article

References (38)

1. Misra A., Ganesh S., Shahiwala A., and Shah S.P. Drug delivery to the central nervous system: a review. J Pharm Pharmaceut Sci 6 (2003) 252-273
2. Tosi G., Costantino L., Ruozi B., Forni F., and Vandelli M.A. Polymeric nanoparticles for the drug delivery to the central nervous system. Expert Opin Drug Deliv 5 (2008) 155-174
3. Kerns E., and Di L. Blood brain barrier. Drug-Like Properties: Concepts, Structure Design and Methods (2008), Academic Press, San Diego, CA 122-136
4. Costantino L., Gandolfi F., Tosi G., Rivasi F., Vandelli M.A., and Forni F. Peptide-derivatized biodegradable nanoparticles able to cross the blood-brain barrier. J Control Release 108 (2005) 84-96
5. Tosi G., Costantino L., Rivasi F., Ruozi B., Leo E., Vergoni A.V., et al. Targeting the central nervous system: in vivo experiments with peptide-derivatized nanoparticles loaded with loperamide and rhodamine-123. J Control Release 122 (2007) 1-9
6. Castro D.J., Haghighat S., Saxton R.E., Reisler E., Jongwaard N., Castro D.J., et al. Biodistribution of Rhodamine-123 in nude mice heterotransplanted with human squamous cell carcinomas. Laryngoscope 10 (1992) 868-874
7. -/- and wild-type mice. Total brain versus microdialysis concentration profiles of Rhodamine-123. Pharm Res 15 (1998) 1657-1665
8. 99mTc]-Hexakis-(2-methoxyisobutylisonitrile). J Med Chem 41 (1998) 2111-2117
9. Garcia-Garcia E., Andrieux K., Gil S., and Couvreur P. Colloidal carriers and blood-brain barrier (BBB) translocation: a way to deliver drugs to the brain?. Int J Pharm 298 (2005) 274-292
10. Alyautdin R.N., Petrov V.E., Langer K., Berthold A., Kharkevich D.A., and Kreuter J. Delivery of loperamide across the blood-brain barrier with polysorbate 80-coated polybutylcyanoacrylate nanoparticles. Pharm Res 14 (1997) 325-328
11. Michaelis K., Hoffmann M.M., Dreis S., Herbert E., Alyautdin R.N., and Michaelis M. Covalent linkage of apolipoprotein E to albumin nanoparticles strongly enhances drug transport into the brain. J Pharm Exp Ther 317 (2006) 1246-1253
12. Kreuter J., Hekmatara T., Dreis S., Vogel T., Gelperina S., and Langer K. Covalent attachment of apolipoprotein A-I and apolipoprotein B-100 to albumin nanoparticles enables drug transport into the brain. J Control Release 118 (2007) 54-58
13. Esmaeili F., Ghahremani M.H., Esmaeili B., Khoshayand M.R., Atyabi F., and Dinarvand R. PLGA nanoparticles of different surface properties: preparation and evaluation of their body distribution. Int J Pharm 349 (2008) 249-255
14. Ma W., Yuan X., Kang C., Su T., Yuan X., Pu P., et al. Evaluation of blood circulation of polysaccharide surface-decorated PLA nanoparticles. Carbohyd Polymers 72 (2008) 75-81
15. Li Y.P., Pei Y.Y., Zhang X.Y., Gu Z.H., Zhou Z.H., Yuan W.F., et al. PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats. J Control Release 71 (2001) 203-211
16. Gref R., Minamitake Y., Peracchia M.T., Trubeskoy V., Torchilin V., and Langer R. Biodegradable long-circulating polymeric nanospheres. Science 263 (1994) 1600-1603
17. Nam Y.S., Park Y., Han S.H., and Chang I.S. Intracellular drug delivery using poly(d,l-lactide-co-glycolide) nanoparticles derivatized with a peptide from a transcriptional activator protein of HIV-1. Biotechnol Lett 24 (2003) 2093-2098
18. Rao K.S., Reddy M.K., Horning J.L., and Labhasetwar V. TAT-conjugated nanoparticles for the CNS delivery of anti-HIV drugs. Biomaterials 29 (2008) 4429-4438
19. Hu K., Li J., Shen Y., Lu W., Gao X., Zhang Q., et al. Lactoferrin-conjugated PEG-PLA nanoparticles with improved brain delivery: in vitro and in vivo evaluations. J Control Release 134 1 (2008) 55-61 10.1016/Jconrel.2008.10.016
20. Fessi H., Puisieux F., Devissaguet J.P., Ammoury N., and Benita S. Nanocapsule formation by interfacial polymer deposition following solvent displacement. Int J Pharm 55 (1989) R1-R4
21. Chen H., Gaul F., Gou D., and Maycock A. Determination of loperamide in rat plasma and bovine serum albumin by LC. J Pharm Biomed Anal 22 (2000) 555-561
22. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates (1997), Academic Press, New York
23. Eddy N.B., and Leimbach D. Synthetic analgesic. II. Dithienylbutyl and dithienylbutylamines. J Pharm Exp Ther 107 (1953) 385-395
24. Rezayat M., Rahnavard A., and Zarrindast M. Role of cholecystokinin receptors in induction of antinociception in hot-plate test. Pharmacol Toxicol 87 (2000) 58-62
25. Rafati H., Coombes A.G.A., Adler A., Holland J., and Davis S.S. Protein-loaded poly(d,l-lactide-co-glycolide) microparticles for oral administration: formulation, structural and release characteristics. J Control Release 43 (1997) 89-102
26. Huang X., Chestang B.L., and Brazel C.S. Minimization of initial burst in poly(vinyl alcohol) hydrogels by surface extraction and surface-preferential crosslinking. Int J Pharm 248 (2002) 183-192
27. Cohen S., Yoshioka T., Lucarelli M., Huang L.H., and Langer R. Controlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheres. Pharm Res 8 (1991) 713-720
28. Sah H.K., Toddywala R., and Chien Y.W. The influence of biodegradable microcapsule formulations on the controlled release of a protein. J Control Release 30 (1994) 201-211
29. Batycky R.P., Hanes J., Langer R., and Edwards D.A. A theoretical model of erosion and macromolecular release from biodegrading microspheres. J Pharm Sci 86 (1997) 1464-1477
30. Uchida K., Yagi A., Oda Y., and Goto S. Microencapsulation of ovalbumin in poly(lactide-co-glycolide) by and oil-in-oil (o/o) solvent evaporation method. J Microencaps 13 (1996) 509-518
31. Panagi Z., Beletsi A., Evangelatos G., Livaniou E., Ithkissios D.S., and Avgoustakis K. Effect on the biodistribution and pharmacokinetics of PLGA and PLGA-mPEG nanoparticles. Int J Pharm 221 (2001) 143-152
32. Calvo P., Gouritin B., Chacun H., Desmaele D., D'Angelo J., Noel J.P., et al. Long-circulating PEGylated polycyanoacrylate nanoparticles as a new drug carrier for brain delivery. Pharm Res 18 (2001) 1157-1166
33. 3H-labelled dalargin bound to poly(butylcyanoacrylate) nanoparticles after i.v. injection to mice. Life Sci 66 (2000) 495-502
34. 14C poly(d,l-lactide-co-glycolide) nanoparticles after intravenous and oral administration to mice. Int J Pharm 106 (1994) 201-211
35. 14C-poly(methylmetacrylate) nanoparticles in experimental tumor models. Pharm Res 18 (2001) 1613-1619
36. 14C -poly(butyl cyanoacrylate) nanoparticles after intravenous administration to glioblastoma-bearing rats. J Drug Target 14 (2006) 97-105
37. Brigger P., Morizet J., Aubert G., Chacun H., Terrier-Lacombe M.J., Couvreur P., et al. Poly(ethylene glycol)-coated hexadecylcyanoacrylate nanospheres display a combined effect for brain tumor targeting. J Pharmacol Exp Ther 303 (2002) 928-936
38. Brigger I., Morizet J., Laudani L., Aubert G., Appel M., Velasco V., et al. Negative preclinical results with stealth nanospheres-encapsulated doxorubicin in an orthotopic murine brain tumor model. J Control Release 100 (2004) 29-40